Moneycontrol PRO
Loans
Loans
HomeNewsBusinessEarningsAbbott India Q1 FY26 Net Profit Rises 7.27% YoY to ₹365.86 Crore

Abbott India Q1 FY26 Net Profit Rises 7.27% YoY to ₹365.86 Crore

Abbott India Q1 FY26 Net Profit Rises 7.27% YoY to ₹365.86 Crore

August 12, 2025 / 13:45 IST
Disclaimer This is an AI-assisted live blog with updates sourced from multiple news outlets and agencies Disclaimer
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Abbott India reported a 7.27% year-on-year increase in consolidated net profit to ₹365.86 crore for the first quarter of FY26. Revenue from operations grew by 11.16% to ₹1,738.35 crore.

 

Q1 FY26 Financial Results (in ₹ crore)
MetricQ1 FY26Q1 FY25YoY ChangeQ4 FY25QoQ Change
Net Profit365.86328.01+7.27%367.04-0.32%
Revenue from Operations1,738.351,557.58+11.16%1,604.59+8.34%
Other Income72.8467.33+8.18%76.02-4.18%
Total Income1,811.191,624.94+11.05%1,680.61+7.77%

 

Financial Performance

The company's cost of materials consumed was ₹146.18 crore in Q1 FY26, compared to ₹146.28 crore in Q1 FY25.

Purchases of stock-in-trade amounted to ₹868.79 crore, up from ₹781.30 crore in the same quarter last year.

Changes in inventories of finished goods, stock-in-trade, and work-in-progress was -₹72.85 crore, compared to -₹81.22 crore in Q1 FY25.

Employee benefits expense stood at ₹168.01 crore, compared to ₹161.06 crore in the corresponding quarter of the previous year.

Finance costs were ₹5.82 crore, up from ₹2.75 crore in Q1 FY25.

Depreciation and amortisation expense was ₹19.48 crore, compared to ₹18.37 crore in the same quarter last year.

Other expenses amounted to ₹182.63 crore, up from ₹159.18 crore in Q1 FY25.

Total expenses for the quarter were ₹1,318.06 crore, compared to ₹1,187.72 crore in the same quarter last year.
<Other Comprehensive Income

Other comprehensive income for the period, net of tax, was ₹0.04 crore, compared to ₹0.01 crore in Q1 FY25.
<Earnings Per Share

The basic/diluted earnings per share was ₹172.17 compared to ₹154.36 in Q1 FY25.

The above financial results have been reviewed and recommended by the Audit Committee and thereafter approved by the Board of Directors at their meetings held on August 12, 2025.

The financial results for quarter ended June 30, 2025 have been subjected to limited review by the statutory auditors of the Company.

The Company has only one segment which is 'Pharmaceuticals'.

Figures for the previous periods have been regrouped/reclassified wherever considered necessary.

For and on behalf of the Board of Directors of Abbott India Limited

Kartik Rajendran

Managing Director

DIN: 09527717

The basic/diluted earnings per share was ₹172.17 compared to ₹154.36 in Q1 FY25.

Alpha Desk
first published: Aug 12, 2025 01:45 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347